Page last updated: 2024-11-06

prednisolone and Cerebellar Dyssynergia

prednisolone has been researched along with Cerebellar Dyssynergia in 2 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Research Excerpts

ExcerptRelevanceReference
" These patients were divided into four treatment groups based on corticosteroid dosage and use of an antiviral agent."1.72Benefits of High-Dose Corticosteroid and Antiviral Agent Combination Therapy in the Treatment of House-Brackman Grade VI Ramsay Hunt Syndrome. ( Abe, Y; Furukawa, T; Goto, T; Hull, M; Ito, T; Kakehata, S; Kubota, T; Sugiyama, M, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Furukawa, T1
Abe, Y1
Ito, T1
Kubota, T1
Hull, M1
Goto, T1
Sugiyama, M1
Kakehata, S1
Ho, TH1
Chou, CH1

Other Studies

2 other studies available for prednisolone and Cerebellar Dyssynergia

ArticleYear
Benefits of High-Dose Corticosteroid and Antiviral Agent Combination Therapy in the Treatment of House-Brackman Grade VI Ramsay Hunt Syndrome.
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2022, 08-01, Volume: 43, Issue:7

    Topics: Adrenal Cortex Hormones; Antiviral Agents; Bell Palsy; Facial Paralysis; Herpes Zoster Oticus; Human

2022
Ramsay Hunt syndrome type II.
    QJM : monthly journal of the Association of Physicians, 2019, Jan-01, Volume: 112, Issue:1

    Topics: Acyclovir; Aged; Herpes Zoster Oticus; Herpesvirus 3, Human; Humans; Male; Myoclonic Cerebellar Dyss

2019